English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Tabitha Fleming
| Jun 2, 2017
Merck's Keytruda approved for treating Hodgkin's lymphoma in Europe
Trending
+
Pharmaceuticals
Patient Daily
| Jun 30, 2025
PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+
Pharmaceuticals
Patient Daily
| Jun 23, 2025
PhRMA says patients in the U.S. face higher prescription costs due to 340B program
+
Pharmaceuticals
Patient Daily
| Jun 25, 2025
Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
« First
«
…
3
4
5
6